๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer: Two years later

โœ Scribed by Anna A. Kasperlik-Zaluska; Barbara M. Migdalska; Anna M. Makowska

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
150 KB
Volume
78
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Impact of adjuvant mitotane on the clini
Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer
โœ Rena Vassilopoulou-Sellin; Mary J. Klein; Pamela N. Schultz; Naguib A. Samaan; V ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 456 KB ๐Ÿ‘ 2 views

Background. Adrenocortical carcinoma is a rare and aggressive disease with a poor prognosis. Adjuvant mitotane administration has been suggested as a strategy that might improve the outcome of patients with localized disease. Methods. The authors analyzed the clinical out- come of patients with loc

The impact of stage and histology on the
The impact of stage and histology on the long-term clinical course of 163,808 patients with breast carcinoma
โœ John W. Gamel; John S. Meyer; Eric Feuer; Barry A. Miller ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 491 KB

## BACKGROUND. Stage and histologic type have a significant impact on the long term clinical course of breast carcinoma. Clinical course is governed by two components: likelihood of cure and median tumor-related survival time among uncured patients. Estimates of these components can be derived only